Company Overview - Company stock price on August 20 was 8.76 yuan, down 0.02 yuan from the previous trading day, a decrease of 0.23% [1] - The trading volume on that day was 71,122 hands, with a transaction amount of 0.62 billion yuan [1] - Company operates in the medical device industry, focusing on the research, production, and sales of clinical immunochemistry luminescent diagnostic testing products [1] Product and Service Range - Company’s products cover multiple testing areas including infectious diseases, tumor markers, thyroid function, and sex hormones [1] Financial Performance - In the first quarter of 2025, the company achieved operating revenue of 81.3 million yuan and a net profit of 14.54 million yuan [1] Corporate Governance - On August 20, the company announced that the board of directors has approved a proposal for a board re-election, nominating 6 non-independent director candidates and 3 independent director candidates [1] - The company plans to change its auditing firm for the 2025 fiscal year to Rongcheng Accounting Firm [1] Capital Flow - On August 20, the net inflow of main funds was 378,700 yuan, accounting for 0.01% of the circulating market value [1] - Over the past five days, the net outflow of main funds was 48.88 million yuan, representing 1.39% of the circulating market value [1]